Loading stock data…
Quanterix Corporation (QTRX)
$3.67-0.25 (-6.38%)
Market ClosedLast close Jul 24
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Quanterix Corporation in the Healthcare sector is trading at $3.67 with a market capitalization of $145M. Wall Street consensus targets $4.33 (3 analysts), implying a +18.1% move over the next 12 months. The stock is currently 58% below its 52-week high of $8.77, remaining 26.6% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Sell-side targets imply +18.1% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 34) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $36.41M↓ | $43.78M↑ | $40.15M↑ | $24.45M↓ | $30.33M |
| Gross Profit | $15.57M↓ | $19.96M↑ | $17.12M↑ | $11.28M↓ | $14.84M |
| Operating Income | -$21.53M↑ | -$23.87M↑ | -$30.15M↓ | -$29.43M↓ | -$26.37M |
| Net Income | -$17.54M↑ | -$23.12M↑ | -$33.52M↓ | -$30.01M↓ | -$20.50M |
Peer Comparison
JNJUNHPFE
Fundamentals
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Si...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$145.09M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-36.93%
Volume
Today's trading volume
423,765
Recent News
Quanterix (QTRX) Stock Fair Value Falls After Analysts Cut Price Targets
Quanterix is back in focus after analysts trimmed their fair value price target from US$5.33 to US$4.33, tightening the implied upside range for the stock. Research firms describe this as a recalibration tied to refreshed assumptions rather than a wholesale change in the core outlook on Quanterix. Read on to see what is driving the revised targets, how bullish and cautious voices differ, and what it could mean for investors following the evolving narrative from here. Analyst Price Targets...
TRIB, QTRX, RCON: Why These Stocks Are Surging After-Hours Today
The small-cap stocks surged between 6% and 27% after hours on Tuesday.
Quanterix (QTRX) Q1 2026 Earnings Transcript
Need a quote from a Motley Fool analyst? Joshua Young: Thank you, Preyila, and good afternoon, everybody. With me on today's call are Everett Cunningham, Quanterix' President and CEO; and Vandana Sriram, Quanterix' Chief Financial Officer.
Quanterix Q1 Earnings Call Highlights
Quanterix (NASDAQ:QTRX) reported first-quarter 2026 revenue of $36.4 million, up 20% year-over-year, as leadership outlined operational and commercial changes aimed at improving execution in a challenging end-market backdrop. The company also highlighted stepped-up investment in its Alzheimer’s diag
Quanterix Corporation (QTRX) Reports Q1 Loss, Lags Revenue Estimates
Quanterix (QTRX) delivered earnings and revenue surprises of -25.81% and -0.67%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?